TG Therapeutics (TGTX) had the lowest return on January 10, 2024 by a US stock with a market cap of $2B+, returning -21.2%.

ASSET	DATE	% RETURN
TG Therapeutics (TGTX)	1/10/2024	-21.2%
Purecycle Technologies (PCT)	1/10/2024	-9.9%
QXO (QXO)	1/10/2024	-9.11%
AZZ (AZZ)	1/10/2024	-8.07%
Lucid (LCID)	1/10/2024	-7.81%
Recursion Pharmaceuticals (RXRX)	1/10/2024	-7.62%
GeneDx (WGS)	1/10/2024	-7.24%
Lantheus (LNTH)	1/10/2024	-6.84%
PriceSmart (PSMT)	1/10/2024	-6.68%
Melco Resorts & Entertainment (MLCO)	1/10/2024	-6.44%
Lifestance Health (LFST)	1/10/2024	-6.18%
Enovix (ENVX)	1/10/2024	-5.94%
Pagaya Technologies (PGY)	1/10/2024	-5.79%
Travere Therapeutics (TVTX)	1/10/2024	-5.73%
VNET Group Inc DRC (VNET)	1/10/2024	-5.62%
Ramaco Resources (METC)	1/10/2024	-5.59%
Cellebrite DI (CLBT)	1/10/2024	-5.36%
TMC the metals (TMC)	1/10/2024	-5.23%
Mercurity Fintech Holding Inc ADR (MFH)	1/10/2024	-5.2%
Sotera Health (SHC)	1/10/2024	-5.01%
Medpace (MEDP)	1/10/2024	-4.98%
Alpha Metallurgical Resources (AMR)	1/10/2024	-4.74%
Dyne Therapeutics (DYN)	1/10/2024	-4.73%
ICON (ICLR)	1/10/2024	-4.62%
Mirum Pharmaceuticals (MIRM)	1/10/2024	-4.61%